WHAT YOU WILL LEARN IN THIS VIDEO:
- The current large-scale manufacturing of monoclonal antibodies (mAbs) using conventional packed-bed column technology presents a challenge in the development of an efficient and economical downstream purification process. Conventional packed-bed capture chromatography presents a bottleneck due to low productivity and physical characteristics. An efficient and economical capture chromatography is needed to develop sustainable protein purification processes.
- Over the last two decades, technological progress in Protein A membrane chemistry has contributed to the advancement of novel and more affordable bio-separation devices with high binding capacities and improved mass transfer properties. We are testing Protein A membrane chromatography technology to develop efficient purification processes for our clients.
- Our findings from a recent case study showcased that single-use chromatographic clarification technology can increase productivity by six times at the capture step in mAb purification. These results demonstrated market competitive capabilities of Protein A membrane technology for the commercial purification of mAb products.
This presentation was originally delivered at the 15th Annual Bioprocessing Summit on Aug 15, 2023.
Watch the on demand video by completing the form below:
